Life Sciences Marketing in 2024: What’s Next and Why it Matters

Marcella Milliet Sciorra, chief marketing officer of  Doceree, provides valuable perspectives on the transformative impact of various evolving trends in the pharmaceutical industry. These trends, including AI, Augmented & Virtual Reality, Telehealth, Omnichannel Marketing, and more, are set to revolutionize the strategy for engaging healthcare professionals (HCPs) and enhance the data privacy infrastructure by 2024. As the pharmaceutical industry embraces digital marketing initiatives with great enthusiasm, the landscape of HCP engagement and data privacy will undergo significant advancements.

Let’s dive into what’s buzzing in life sciences marketing as we gear up for 2024. It’s an exciting time, with digital transformation opening doors left and right. Remember the massive shake-up from that global pandemic back in 2019? Well, it set off a chain reaction, pushing the life sciences field, especially the pharma sector, into uncharted territories.

2023: A Year of Breakthroughs and New Paths

This past year was a game-changer. We saw techs like Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), clean rooms, and blockchain starting to reshape everything from research to marketing in life sciences. Over half the finance leadersOpens a new window in pharma are now aiming at digital transformation, according to Within3.

Engaging Healthcare Pros: The 2024 Challenge

While engaging healthcare professionals (HCPs) is very complex, it is certainly not impossible with technology that unifies the fragmented HCP marketing ecosystem. The coming year will continue to bring tech breakthroughs and changing consumer expectations. It’s about getting tech and trends to work for us and ensuring we hit the mark in HCP engagement for better business results.

Here are the top emerging trends that will redefine marketing approaches within the life sciences industry in 2024.

Tailoring the Message: Harnessing The Digital Wand

Despite healthcare digital transformation, some marketers are still on the fence. A 2023 survey by MM+MOpens a new window found a split camp: while over half see personalized communication as a golden ticket, many still struggle with reaching the so-called ‘no-see docs.’ The key? Creating custom experiences for HCPs, informed by data, understanding their needs, and helping them provide patient-centric information at critical moments of care to improve health outcomes. 

Rise of Immersive Technologies: AR and VR Redefining Engagement

AR and VR are more than just cool tech – they’re transforming how we present life sciences products. This tech isn’t just about flashy demos; it’s a practical tool that makes products understandable and relatable. Imagine healthcare professionals, researchers, and even patients stepping into a virtual world where they can get up close and personal with medicines and treatments. It’s like test driving a car, but for healthcare products.

Data and AI: The Power Duo

The global life sciences market is booming and expected to reach a staggering USD 27965.6 Million by 2028Opens a new window . This growth isn’t just about bigger numbers; it’s about the increasing complexity and volume of data that organizations in this space must manage and interpret. Artificial Intelligence (AI) stands out as a pivotal tool in this context, offering solutions to tackle data fragmentation and providing healthcare professionals with rapid insights into some of their most challenging business questions.

AI’s potential in healthcare extends far beyond data management. For physicians, AI can be a game-changer in optimizing patient treatment plans. It can analyze a patient’s fragmented medical history, integrating disparate data points from various sources to provide a comprehensive view. This holistic approach enables physicians to make more informed decisions, tailor treatments to individual patient needs, and potentially improve outcomes. 

AI can delve into complex datasets for healthcare marketers to extract actionable insights, helping them fine-tune their strategies across various channels. In the realm of omniscreen HCP (Healthcare Professional) campaigns, AI can analyze engagement across different platforms – from digital ads and social media to electronic health record and ePrescribing platforms. This analysis can reveal which channels are most effective, how messaging resonates with different segments of the HCP audience, and where adjustments might increase campaign effectiveness.

Telehealth and Digital Therapeutics: The New Frontier

Telehealth is rapidly becoming more than just a trend; it’s shaping to be the backbone of future healthcare. The surge in investment in digital therapeutics and health apps underscores its growing importance. These innovations focus on delivering convenience, accessibility, and tangible health outcomes. For perspective, the U.S. electronic health record (EHR) market is expected to surpass $9.1 million this year, and the global telehealth market has reached approximately $101.2 billion in 2033, with these figures expected to climb as the technology and its adoption evolve.

A significant driver of telehealth’s growth is its pivotal role in chronic illness management. Patients with long-term conditions benefit immensely from remote monitoring and virtual consultations, which offer more frequent and convenient touchpoints with healthcare providers (HCPs). This model enhances patient engagement and adherence to treatment plans and allows for timely interventions, potentially reducing hospital admissions and overall healthcare costs.

Global giants like Amazon are recognizing the potential and are investing heavily in healthcare solutions. Amazon’s entry into the healthcare space, through initiatives like Amazon Care and its online pharmacy, signals a shift towards more integrated, tech-driven healthcare solutions. Their presence will likely spur innovation and competition, leading to more advanced, user-friendly, and cost-effective healthcare services.

See More: Improving CX Within Healthcare Organizations

Privacy-forward Marketing: The Priority

Data privacy in the life sciences sector has never been more critical, and it’s about much more than just ticking boxes on a compliance checklist. It’s a fundamental aspect of doing business ethically and transparently. Today, data is akin to currency. The way companies handle this precious resource can make or break their reputation. Privacy isn’t just a regulatory requirement; it’s about doing the right thing, building trust with consumers and healthcare professionals, and fostering innovation within a framework that respects individual privacy rights. Adopting a privacy-forward approach ensures that marketing efforts are compliant and aligned with the evolving expectations of a privacy-conscious public. 

As we look ahead to 2024, a significant challenge confronting the industry is the fragmentation of privacy regulations on a global scale. Each region, and often each country or state within a country, has its own set of privacy laws and regulations, which can vary widely in their requirements and enforcement. This fragmented landscape poses a complex challenge for marketers in the life sciences sector. Marketers need to partner with companies that deeply understand local regulations and employ non-biased algorithms in their models. These partners should be able to demonstrate how their products and solutions comply with the specific rules of each market. Transparency in these partnerships is essential; it’s not enough to claim compliance. It’s necessary to show it with clear, understandable explanations of how their technology and practices adhere to relevant laws and protect user privacy. 

Omnichannel and Opti-channel: The Integrated Approach

An omnichannel strategy is key for a consistent brand experience across healthcare marketing. For life science marketers specifically, the omnichannel strategy requires next best engagement (NBE) or next best action (NBA) platform at the core, real-time data push and pull from digital partners, an interoperable creative platform to deliver the right message to the right channel, real-time measurement against pharma specific KPIs (like NRx, NBRx, TRx). A true omnichannel strategy must ensure that every engagement with your target audience builds on the previous messaging and adds value to push the target down the decision funnel. Otherwise, it is simply a multi-channel approach. 

Wrapping Up: 2024 and Beyond

So, what’s the takeaway as we look towards 2024? It’s about riding the wave of technology, personalization, and a stronger focus on privacy-forward practices. Staying flexible and informed is vital in this fast-evolving field. Embracing these trends is not just a choice; it’s essential for companies looking to stay relevant and make a mark in the competitive world of life sciences marketing.

What strategies are you employing to navigate the evolving field of life sciences marketing? Share with us on FacebookOpens a new window , XOpens a new window , and LinkedInOpens a new window . We’d love to hear from you! 

Image Source: Shutterstock

MORE ON LIFE SCIENCES

• IT Leaders in Emerging Life Sciences: Five Tips to Drive Your IT and Compliance Strategy
• Why CIOs Are Leading Business Development for Life Sciences
• IoT Is Transforming the Life Science Industry
• Why Simple Tools, Collaboration, and Secure Data Management Are a Must for the Biotech Industry
• How Real-World Data Supports Pharmaceutical Drug Development